BNB Falls Below $800 Despite Corporate Buying, Highlighting Fragile Market Support

BNB slipped below the key $800 mark on Tuesday, underscoring fragile market support despite a surge of interest from public companies and corporate treasuries.

The token dropped from approximately $815.80 to an intraday low of $780 before recovering slightly to trade just below $795. The decline marked a breach of the widely watched psychological support at $800, raising concerns about the sustainability of recent gains.

CoinDesk Research’s technical model recorded a sharp spike in activity during the decline, with trading volumes exceeding 4,000 tokens per minute — a sign of heightened rebalancing and volatility.

The pullback follows BNB’s recent rally to a record high near $860, driven in part by aggressive accumulation from publicly listed firms. CEA Industries (VAPE), backed by Binance co-founder Changpeng Zhao’s family office Yzi Labs, said last week it plans to raise up to $1.2 billion to establish what it claims will be the largest BNB treasury held by a U.S.-listed company. VAPE shares soared over 700% following the news.

Several other companies have also disclosed significant BNB initiatives. Liminatus Pharma (LIMN) launched a dedicated subsidiary targeting $500 million in BNB acquisitions, while Windtree Therapeutics (WINT) revealed a $700 million BNB allocation plan. Separately, Nano Labs reported a purchase of 128,000 BNB after announcing a new crypto treasury strategy.

Despite this wave of corporate interest, volume and price action suggest a lack of sustained demand at higher levels. Resistance around $815.40 saw considerable selling pressure, and the swift rejection of that level implies profit-taking or hesitation among buyers.

While a modest late-session rebound offers some evidence of market support, technical indicators continue to point to vulnerability. Without broader confirmation of demand beyond corporate inflows, BNB’s breakout risks remain elevated in the near term.